Porcupine's dilemma in kidney fibrosis

Hiroshi Nishi1

  • 1Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

Kidney International
|November 25, 2019
PubMed

Insights

Porcupine inhibition can treat kidney fibrosis. In this study, porcupine in kidney tubules worsened fibrosis, but in myeloid cells, it had a protective effect, highlighting its complex role in Wnt/β-catenin signaling.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Aberrant Wnt/β-catenin signaling promotes kidney fibrosis.
  • Porcupine (a membrane-bound O-acyltransferase) is a key regulator of Wnt/β-catenin signaling.
  • Previous studies showed porcupine inhibitors can attenuate kidney fibrosis.

Purpose of the Study:

  • To investigate the specific roles of porcupine in different kidney cell types regarding fibrosis.
  • To understand the dual effects of porcupine in renal tubule and myeloid cells.

Main Methods:

  • Utilized conditional knockout mouse models to delete porcupine in specific cell lineages.
  • Analyzed the impact of porcupine deletion on kidney fibrosis progression.
  • Assessed Wnt signaling activation in response to porcupine modulation.

Main Results:

  • Porcupine expression in renal tubules accelerated kidney fibrosis and Wnt generation.
  • Porcupine expression in myeloid cells counteracted pro-fibrotic effects.
  • These findings reveal cell-specific functions of porcupine in kidney fibrosis.

Conclusions:

  • Porcupine's role in kidney fibrosis is complex and cell-dependent.
  • Targeting porcupine in specific cell types may offer a refined therapeutic strategy for kidney fibrosis.
  • Further research is warranted to explore the therapeutic potential of modulating porcupine in distinct cellular contexts.